Country: United States
Sector: Health Care
Website: http://www.shattucklabs.comShattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion